Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease.

Balázs SzirmayAndrás TárnokPatrícia SarlósNóra SzigetiAndrea LudányPéter KustánZoltán Horváth-SzalaiAttila MisetaTamás Kőszegi

Published in: European journal of clinical investigation (2018)

Our findings suggest that u-ORM/u-CREAT might serve as a valuable additional marker in the follow-up of CD patients, especially in children for whom the non-invasive sampling is a further advantage.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
young adults
prognostic factors
patient reported outcomes